JP2011500091A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500091A5
JP2011500091A5 JP2010531283A JP2010531283A JP2011500091A5 JP 2011500091 A5 JP2011500091 A5 JP 2011500091A5 JP 2010531283 A JP2010531283 A JP 2010531283A JP 2010531283 A JP2010531283 A JP 2010531283A JP 2011500091 A5 JP2011500091 A5 JP 2011500091A5
Authority
JP
Japan
Prior art keywords
rate
binding
protein
data
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010531283A
Other languages
English (en)
Japanese (ja)
Other versions
JP5808536B2 (ja
JP2011500091A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/081175 external-priority patent/WO2009055711A2/en
Publication of JP2011500091A publication Critical patent/JP2011500091A/ja
Publication of JP2011500091A5 publication Critical patent/JP2011500091A5/ja
Application granted granted Critical
Publication of JP5808536B2 publication Critical patent/JP5808536B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010531283A 2007-10-25 2008-10-24 抗rsvgタンパク質抗体 Active JP5808536B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46907P 2007-10-25 2007-10-25
US61/000,469 2007-10-25
US8940108P 2008-08-15 2008-08-15
US61/089,401 2008-08-15
PCT/US2008/081175 WO2009055711A2 (en) 2007-10-25 2008-10-24 Anti-rsv g protein antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015006644A Division JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Publications (3)

Publication Number Publication Date
JP2011500091A JP2011500091A (ja) 2011-01-06
JP2011500091A5 true JP2011500091A5 (enExample) 2011-10-27
JP5808536B2 JP5808536B2 (ja) 2015-11-10

Family

ID=40580419

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010531283A Active JP5808536B2 (ja) 2007-10-25 2008-10-24 抗rsvgタンパク質抗体
JP2015006644A Withdrawn JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015006644A Withdrawn JP2015078231A (ja) 2007-10-25 2015-01-16 抗rsvgタンパク質抗体

Country Status (14)

Country Link
US (3) US7736648B2 (enExample)
EP (1) EP2214711B1 (enExample)
JP (2) JP5808536B2 (enExample)
KR (1) KR101671452B1 (enExample)
CN (1) CN101808663B (enExample)
AU (1) AU2008316703B2 (enExample)
BR (1) BRPI0819210A2 (enExample)
CA (1) CA2703667C (enExample)
IL (1) IL205257A (enExample)
MX (1) MX2010004482A (enExample)
NZ (1) NZ585589A (enExample)
RU (1) RU2526517C2 (enExample)
WO (1) WO2009055711A2 (enExample)
ZA (1) ZA201003131B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156888A1 (en) * 2002-11-26 2004-08-12 Jensen Gerard M. Liposomal formulations
NZ585589A (en) * 2007-10-25 2012-07-27 Trellis Bioscience Inc Anti-rsv g protein antibodies
WO2013095091A2 (en) 2011-11-17 2013-06-27 Aimm Therapeutics B.V. Rsv g protein specific antibodies
US10131709B2 (en) 2011-12-28 2018-11-20 Immunoqure Ag Nucleic acid molecules encoding monoclonal antibodies specific for IL-22
AU2013206788B2 (en) * 2011-12-28 2017-11-30 Immunoqure Ag Method of providing monoclonal auto-antibodies with desired specificity
US9546219B2 (en) 2012-02-08 2017-01-17 North Carolina State University Treatment of allergic diseases with recombinant antibodies
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
US10035842B2 (en) 2013-04-15 2018-07-31 Janssen Vaccines & Prevention B.V. Human antibodies binding to RSV G proteins
CN111303278B (zh) * 2013-04-15 2022-09-06 扬森疫苗与预防公司 结合到rsv g蛋白的人类抗体
WO2014170257A1 (en) * 2013-04-15 2014-10-23 Crucell Holland B.V. Human antibodies binding to rsv g protein
WO2015120474A1 (en) * 2014-02-10 2015-08-13 Igm Biosciences, Inc. Iga multi-specific binding molecules
CN103911389A (zh) * 2014-04-09 2014-07-09 南昌大学 一种检测人呼吸道合胞病毒抗体的g和f蛋白的制备方法
RS62870B1 (sr) 2014-12-05 2022-02-28 Memorial Sloan Kettering Cancer Center Himerni antigenski receptori sa ciljanim delovanjem na receptore spregnute sa g-proteinom i njihove upotrebe
SG10201913937QA (en) 2014-12-05 2020-03-30 Memorial Sloan Kettering Cancer Center Antibodies targeting g-protein coupled receptor and methods of use
CN106496324B (zh) * 2015-11-30 2020-01-14 天津昊免生物技术有限公司 一种抗呼吸道合胞病毒的全人源抗体
CN105542003B (zh) * 2016-03-01 2019-12-06 苏州博泰神州生物技术有限公司 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体
EP3538558A4 (en) 2016-11-09 2020-07-15 North Carolina State University TREATMENT OF ALLERGIC DISEASES USING CHIMERIC PROTEIN
SG11201906682YA (en) 2017-01-27 2019-08-27 Ngm Biopharmaceuticals Inc Glucagon receptor binding proteins and methods of use thereof
WO2019075400A1 (en) * 2017-10-13 2019-04-18 Trellis Bioscience, Llc CONFORMATIONAL EPITOPES IN A CENTRAL PROTECTED REGION OF SYNCYTIAL RESPIRATORY VIRUS PROTEIN G
WO2019183437A1 (en) 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for antibody to high affinity receptor for ige
EP3829636A1 (en) 2018-07-27 2021-06-09 NGM Biopharmaceuticals, Inc. Use of glucagon receptor antagonists with immunotherapeutic agent
JP2021534239A (ja) * 2018-08-08 2021-12-09 トレリス・バイオサイエンス,エルエルシー Rsvの改善された受動的および能動的ワクチン
KR102679227B1 (ko) 2019-02-28 2024-06-28 케이엠 바이올로직스 가부시키가이샤 Rsv f/g 키메라 백신
WO2021046390A1 (en) 2019-09-06 2021-03-11 Silgan White Cap LLC Tethered, hinged closure
EP4031171A1 (en) * 2019-09-20 2022-07-27 Universiteit Antwerpen A novel human respiratory syncytial virus strain and its use
EP4429966A1 (en) 2021-11-08 2024-09-18 Silgan White Cap LLC Protrusion on container neck
TW202415409A (zh) * 2022-08-02 2024-04-16 中國商諾納生物(蘇州)有限公司 Msln抗體藥物複合體
WO2025106427A1 (en) * 2023-11-14 2025-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing and protective monoclonal antibodies against respiratory syncytial virus (rsv)
WO2025194126A1 (en) * 2024-03-15 2025-09-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Respiratory syncytial virus (rsv) g and f antibodies with high rsv-neutralizing potency

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3734263B2 (ja) * 1993-05-25 2006-01-11 ワイス・ホールディングズ・コーポレイション 呼吸器シンシチウムウイルスに対するワクチンのためのアジュバント
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
US6642062B2 (en) 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US7083950B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. High affinity fusion proteins and therapeutic and diagnostic methods for use
CA2359776C (en) 1999-01-22 2010-08-03 Ralph A. Tripp Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
ATE412666T1 (de) * 2000-10-18 2008-11-15 Us Gov Health & Human Serv Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
US7413868B2 (en) 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
JP4736037B2 (ja) * 2005-10-26 2011-07-27 株式会社イーベック ヒトgm−csfに結合するヒトのモノクローナル抗体並びにその抗原結合部分
CN1986569A (zh) * 2005-12-23 2007-06-27 首都儿科研究所 人源抗呼吸道合胞病毒中和性基因工程Fab抗体
WO2007094423A1 (ja) * 2006-02-15 2007-08-23 Evec Incorporated ヒトサイトメガロウイルスに結合するヒトのモノクローナル抗体並びにその抗原結合部分
KR20080113223A (ko) * 2006-03-06 2008-12-29 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
CA2657123A1 (en) 2006-07-12 2008-01-17 Trellis Bioscience, Inc. Cellspottm applications
NZ585589A (en) * 2007-10-25 2012-07-27 Trellis Bioscience Inc Anti-rsv g protein antibodies

Similar Documents

Publication Publication Date Title
JP2011500091A5 (enExample)
IL275743A (en) New bispecific format suitable for use in high-through-put screening
JP2018023398A5 (enExample)
HRP20230844T1 (hr) Anti-cd3 antitijela, bispecifične molekule koje vežu antigen koji veže cd3 i cd20, i njihove upotrebe
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
JP2014527802A5 (enExample)
JP2014518883A5 (enExample)
JP2012143232A5 (enExample)
JP2010521147A5 (enExample)
JP2018536393A5 (enExample)
JP2021501744A5 (enExample)
JP2014061000A5 (enExample)
JP2018513680A5 (enExample)
RU2011143905A (ru) ПОЛИСПЕЦИФИЧНЫЕ АНТИТЕЛА, ВКЛЮЧАЮЩИЕ АНТИТЕЛА ПОЛНОЙ ДЛИНЫ И ОДНОЦЕПОЧЕЧНЫЕ ФРАГМЕНТЫ Fab
JP2015535828A5 (enExample)
JP2015212284A5 (enExample)
JP2013539361A5 (enExample)
JP2013506428A5 (enExample)
EA201390278A1 (ru) Антитела к ох40 и способы их применения
JP2017510627A5 (enExample)
JP2011237442A5 (enExample)
JP2013535190A5 (enExample)
WO2011064257A3 (de) Monospezifische polypeptidreagenzien
JP2018507254A5 (enExample)
EA201290172A1 (ru) Стабильные полипептиды, вариабельные домены антитела и антагонисты против tnfr1